John Carter

Development and Validation of an Immunoassay for Quantification of Topoisomerase I in Solid Tumor Tissues

Yvonne A. Evrard, Y. Pommier, J. Doroshow, 2012, PloS one.

Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas.

Y. Pommier, L. Rubinstein, L. Jia, 2011, Cancer research.

F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd

Joel Morris, B. Teicher, M. Kunkel, 2021, Molecular Cancer Therapeutics.

In vivo efficacy of an aldehyde degradation product of dimethane sulfonate (NSC 281612) in an orthotopic RXF-393 human renal tumor model

M. Hollingshead, H. Stotler, John Carter, 2005 .

Evidence of in vivo efficacy for the indenoisoquinolines linked with pharmacodynamic markers for γH2AX

Y. Pommier, J. Doroshow, R. Parchment, 2007 .